Literature DB >> 2295955

Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome.

E Shahar1, E G Murphy, C M Roifman.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2295955     DOI: 10.1016/s0022-3476(05)81667-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  9 in total

1.  Intravenous immunoglobulins in severe Guillian-Barre syndrome in childhood.

Authors:  Preeti Shanbag; Cynthia Amirtharaj; Ashish Pathak
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

Review 2.  Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases.

Authors:  Craig M McDonald
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

3.  Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome.

Authors:  H Rantala; M Uhari; M Niemelä
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

4.  Intravenous immunoglobulin in two children with Guillain-Barré syndrome.

Authors:  L D Notarangelo; M Duse; S Tiberti; B Guarneri; A Brunori; A Negrini; A G Ugazio
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

5.  Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.

Authors:  R Korinthenberg; J S Mönting
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

6.  Poliomyelitis-like syndrome following asthmatic attack (Hopkins' syndrome)--recovery associated with i.v. gamma globulin treatment.

Authors:  H A Cohen; A Ashkenasi; H Ring; R Weiss; B Wolach; G Paret; A Barzilai
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

Review 7.  Guillain-Barré syndrome. Clinical manifestations and directions for treatment.

Authors:  J Rees
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

8.  Demonstration of Borrelia burgdorferi infection in a child with Guillain-Barré syndrome.

Authors:  G Horneff; H I Huppertz; K Müller; T Voit; H Karch
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

9.  Guillain-Barré syndrome following immunisation with Haemophilus influenzae type b conjugate vaccine.

Authors:  A Gervaix; M Caflisch; S Suter; C A Haenggeli
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.